Coronary interventions

Similar documents
Benefit of Performing PCI Based on FFR

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

FFR in Multivessel Disease

Bifurcation stenting with BVS

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

What the Cardiologist needs to know from Medical Images

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

Stable Angina: Indication for revascularization and best medical therapy

CLINICAL CONSEQUENCES OF THE

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

J. Schwitter, MD, FESC Section of Cardiology

Rational use of imaging for viability evaluation

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

PCI vs. CABG From BARI to Syntax, Is The Game Over?

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

Evaluating Clinical Risk and Guiding management with SPECT Imaging

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

Revascularization for Patients with HFrEF: CABG and PCI and the Concept of Myocardial Viability

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

CASE from South Korea

Coronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?

Fractional Flow Reserve and the Results of the FAME Study

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

Management of stable CAD FFR guided therapy: the new gold standard

Fractional Flow Reserve: Review of the latest data

Debate Should we use FFR? I will say NO.

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Management of High-Risk CAD : Surgeons Perspective

Αγγειοπλαστική σε Nόσο Στελέχους: Που βρισκόμαστε. Βάιος Τζίφος Δ/ντής Τμήματος Επεμβατικής Καρδιολογίας Τομέας Καρδιάς Ερρίκος Ντυνάν Hospital Center

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Important LM bifurcation studies update

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

FFR Incorporating & Expanding it s use in Clinical Practice

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

PCI Update Qesaria 2009

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

Unprotected LM intervention

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Imaging and heart failure

Typical chest pain with normal ECG

Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

What do the guidelines say?

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

Coronary stenting: the appropriate use of FFR

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Relations of Interest

Instantaneous Wave-Free Ratio

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

FFR in Left Main Disease

LM stenting - Cypher

Trial. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches

The Case for PCI as the Preferred Therapy in Most Patients with Chronic Stable Angina

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

Clinical Considerations for CTO

The Role of Nuclear Imaging in Heart Failure

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy

Case Review: Borderline LM with IVUS and FFR. Ravi Ramana, DO Heart Care Centers of Illinois SCAI Annual Conference 2010

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

Controversies in Cardiac Surgery

J aborde toute les CTO.

Clinical Considerations for CTO Revascularization

COMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil

Fractional Flow Reserve. A physiological approach to guide complex interventions

Cardiologic history. Anamnesis. Female BD Risk factors HTN, DM, Dyslipidaemia. Cardiologic Long history. Last admission Heart failure

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators

Incidence and Treatment for LM In-Stent

IVUS vs FFR Debate: IVUS-Guided PCI

Chronic Total Occlusion: A case for coronary artery bypass grafting

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

FFR? FFR-CT? Ischaemia testing?

Integrated Use of IVUS and FFR for LM Stenting

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Better CABGs vs Better PCI Devices

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Pearls & Pitfalls in nuclear cardiology

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Cindy L. Grines MD FACC FSCAI

Clinical case in perspective. Cases from Poland

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

Clinical Summary. Live Cases I - IX

Transcription:

Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan

none DECLARATION OF CONFLICT OF INTEREST

CHF aetiology Randomized trials 13 randomized trials on CHF n=20198 n=3164 68% CAD 32% Non-CAD 64% CAD 36% Non-CAD Gheorgiade M. et all. Circulation 1988,97,202 Cleland JGF et all. Eur Heart J 2001,22,1601 Coronary artery disease is the underlying cause in approximately two thirds of patients with heart failure with

Diagnostic modalities in patients with HF & possible CAD

Indications for Coronary Angiography in Patients with Heart Failure Heart failure patients with angina Patients with prior myocardial infarction or known CAD Patients with a strong risk factor profile Patients with unexplained heart failure Patients with positive functional tests Heart failure patients with severely dyskinetic myocardium

What determines the risk of patients with HF and coronary atherosclerosis?

Impact of Ischemia on Risk of Cardiac Death 10, 627 patients having exercise or adenosine MPI Follow-up for 1.9 + 0.6 years Inducible ischemia and severity of angina were independent predictors for death Hachamovitch et al. Circulation 2003;107:2900-2907

Death or MI Rate (%) COURAGE Nuclear Substudy the risk of death / MI according to residual ischemia 40% p=0.002 39,3% 30% p=0.023 20% p=0.063 15,6% 22,3% 10% 0% 0,0% 0% (n=23) 1%-4.9% (n=141) 5%-9.9% (n=88) >10% (n=62) Shaw LJ. et al. Circulation 2008;117:1283-1291

COURAGE Nuclear Substudy Ischemia reduction reduces events 105 Patients with >10% Baseline Ischemia 83.8% 66% Rate of death/mi over 3.5 years was 16% among patients with significant ischemia reduction compared with 34% without Shaw LJ. et al. Circulation 2008;117:1283-1291

COURAGE Nuclear Substudy PCI reduces ischemia better than OMT alone Shaw LJ. et al. Circulation 2008;117:1283-1291

Revascularization Reduces the Risk of Cardiac Death 10, 627 patients having exercise or adenosine MPI Follow-up for 1.9 + 0.6 years Hachamovitch et al. Circulation 2003;107:2900-2907

log Hazard Ratio (Mortality) Log Hazard Ratio as a Function of Ischemic Myocardium 1 N=5366 F/U=2.8 yrs Cardiac death Medical Rx* Revascularization* 0 0 12.5% 25% 32.5% 50% *p<0.001 % of Total Myocardium Ischemic Hachamovitch et al. Circulation 2003;107:2900-2907

Reducing ischemia reduces death and MI

Revascularization Efficacy Depends on the Degree of Ischemia at Baseline

Revascularization Efficacy Depends on the Degree of Ischemia at Baseline

Revascularization, by reducing ischemia reduces death and MI!!!

Stenosis Ischemia

Stenosis Ischemia 69 yo male, inferior MI 3 years before. Dyspnoea, fatigue, EF ~ 40% CTO of RCA Angiographicaly significant stenosis at the ostium of LCx

FAME study: Procedural Results (1) ANGIO-group N=496 FFR-group N=509 P-value # indicated lesions per patient 2.7 ± 0.9 2.8 ± 1.0 0.34 FFR results Lesions succesfully measured, No (%) - 1329 (98%) - Lesions with FFR 0.80,No (%) - 874 (63%) - Lesions with FFR > 0.80,No (%) - 513 (37%) - stents per patient 2.7 ± 1.2 1.9 ± 1.3 <0.001 Lesions succesfully stented (%) 92% 94% - DES, total, No 1359 980 - N Engl J Med 2009; 360: 213-224

FAME study: Event-free Survival absolute difference in MACE-free survival p=0.02 FFR-guided Angio-guided 30 days 2.9% 90 days 3.8% 180 days 4.9% 360 days 5.3% N Engl J Med 2009; 360: 213-224

MR Transmural necrosis (>75%) & hypoperfusion

Left Ventricular Function After Percutaneous Recanalization of Chronic Total Coronary Occlusions SWT before stenting SWT 5 months after stenting SWT 3 years after stenting Kirschbaum,et al. Am J Cardiol 2008;101:179 185

Impact of Revascularization on Prognosis in Pts With CAD and LV Dysfunction: a meta-analysis 3088 patients, mean EF 32 ± 8% FU 25 ± 10 months Allman KC et al. JACC 2002;39:1151 8

Impact of Revascularization on Prognosis in Pts With CAD and LV Dysfunction: a meta-analysis left ventricular EF and predicted change in mortality for patients with viable versus nonviable myocardium Left ventricular EF in % Allman KC et al. JACC 2002;39:1151 8

Stenosis Ischemia Revascularization will not help and may be harmful! Little/no viable myocardium Stenosis functionally not significant

What revascularization? PCI? CABG?

Risk stratification scores

3 Vessel Disease

SYNTAX Score 11

3 Vessel Disease

SYNTAX Score = 52

Patients with CHF and left ventricular EF 35%, predominantly with anginal symptoms SVR surgical ventricular reconstruction

Patients with CHF and left ventricular EF 35%, predominantly with HF symptoms

69 YO man, admitted for heart failure NYHA class IV Severe aortic stenosis, VA ~ 0,6 cm 2 previous anterior MI, current left ventricular EF 25% Stroke 2x (mild disability), IDDM, CKD (egfr 40 ml/min/1.73 m 2 ) EuroSCORE 11 (28%)

69 YO man, admitted for heart failure NYHA class IV Severe aortic stenosis, VA ~ 0,6 cm 2 previous anterior MI, current left ventricular EF 25% Stroke 2x (mild disability), IDDM, CKD (egfr 40 ml/min/1.73 m 2 ) EuroSCORE 11 (28%) Critical distal LM stenosis Significant mid RCA stenosis

PCI LM stenting with 3.5x28 DES Kissing balloon post dilatation

LAD dissection LAD stenting with 3.0x23 DES

Acute result after LM/LAD stenting Acute result after RCA stenting

After 3 months patient s clinical status improved substantially NYHA class II/III ECHO: left ventricular EF increased to 35% Before PCI EF = 25% After 3 months EF = 35%

Control angiography six months after PCI (before TAVI) LCA RCA

Aortic angiography before TAVI (mild AR)

Aortic angiography after CoreValve implantation Fife months after TAVI patient is alive in NYHA class II heart failure

Take-home message Coronary artery disease is the underlying cause in approximately two thirds of patients with heart failure with depressed systolic function Angina is a simple predictor of ischemia, but heart failure patients are often asymptomatic with regard to ischemic symptoms (dyspnoea may be the leading symptom) Ischemia is an independent predictor of death / MI in HF patients

Take-home message (cont.) Assessment of myocardial viability is of utmost importance to detect ischemic but viable myocardium for potential coronary interventions Revascularization (PCI/CABG) is the best method to decreased the risk of death in HF patients with persistent myocardial ischemia. In CABG patients the benefits of coronary artery revascularization need to be balanced against the risks of surgery, which can be substantial in the presence of severe HF